Vical Inc (VICL.OQ)
VICL.OQ on NASDAQ Stock Exchange Global Select Market
4.05USD
1 Aug 2013
4.05USD
1 Aug 2013
Price Change (% chg)
$0.19 (+4.92%)
$0.19 (+4.92%)
Prev Close
$3.86
$3.86
Open
$3.90
$3.90
Day's High
$4.50
$4.50
Day's Low
$3.87
$3.87
Volume
257,587
257,587
Avg. Vol
191,278
191,278
52-wk High
$4.73
$4.73
52-wk Low
$2.61
$2.61
About
Vical Incorporated researches and develops biopharmaceutical products based on its deoxyribonucleic acid (DNA) delivery technologies for the prevention and treatment of serious or life-threatening diseases. The Company has three active independent clinical and preclinical development programs in the areas of infectious disease... (more)
Overall
| Beta: | 1.61 |
| Market Cap (Mil.): | $333.69 |
| Shares Outstanding (Mil.): | 86.45 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| VICL.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 47.13 | 37.76 |
| EPS (TTM): | -0.37 | -- | -- |
| ROI: | -33.36 | -2.58 | 18.76 |
| ROE: | -33.96 | -2.66 | 19.59 |
Competitors
| Price | Change | |
|---|---|---|
| Sanofi SA (SASY.PA) | €76.98 | -3.19 |
| Novartis AG (NOVN.VX) | CHF66.60 | +0.35 |
| GlaxoSmithKline plc (GSK.L) | 1,705.50p | +21.50 |
| AstraZeneca plc (AZN.L) | 3,331.50p | -3.50 |
| Merck & Co., Inc. (MRK.N) | $48.45 | +0.28 |
| Pfizer Inc. (PFE.N) | $29.31 | +0.08 |
| Roche Holding Ltd. (ROG.VX) | CHF228.00 | -3.50 |
| Bristol Myers Squibb Co. (BMY.N) | $43.69 | +0.45 |
| Bristol Myers Squibb Co. (BMYMP.PK) | -- | -- |
| Amgen, Inc. (AMGN.OQ) | $108.94 | +0.65 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Pechala's Reports
|
$25.00
|
|
Provider: S&P Capital IQ Quantitative Report
|
$69.00
|
|
Provider: Pechala's Reports
|
$15.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

